Pluri Inc【PLUR】株式ニュース

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Two regenerative aesthetic and longevity products, with clinically validated ingredients, are expected to reach...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement

HAIFA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Pluri Inc. (“Pluri” or the “Company”) (Nasdaq, TASE: PLUR...

Form 8-K - Current report

Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent

Expands patent protection across major global pharmaceutical markets, including the U.S., China and...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

HAIFA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq...

FDApproved 2日前

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing
Two regenerative aesthetic and longevity products, with clinically validated ingredients , are expected to reach the U.S. market during 2026, entering a rapidly expanding U.S. medical aesthetics market, projected to reach $90 billion by 2030
https://markets.businessinsider.com/news/stocks/pluri-advances-toward-u-s-commercial-launch-through-its-subsidiary-cellav-following-completion-of-regenerative-aesthetic-products-listing-1036217213

👍️ 1

FDApproved 2週前

Just Watched Yaky Yanay's AGP Presentation! (Laser Focused on Revenue Streams) !!!

He Reminded Shareholders That Ever After Foods Alone, Currently Has A Valuation of 60 Million!
Also, They Are Waiting For FDA/EMA/IMoH Approvals For CellaV Products Any Day Now !!!

👍️ 1

FDApproved 4週前

EP4735027 - GENETICALLY ENGINEERED MUCOSAL-ASSOCIATED INVARIANT T (MAIT) CELLS FOR ADOPTIVE TRANSFER CELL THERAPY

https://patentscope.wipo.int/search/en/detail.jsf?docId=EP478576522&_cid=P11-MP18X7-75284-1

👍️ 1

Scott999 1月前

Wow they’ve entered the beauty and wellness space without a dozen releases to hype it up. Sweet. Another industry they’ll do nothing in.

I love how they still keep CLI, gvhd and ARS on their presentation. Doesn’t matter if they all failed, these things drive raises. Hopefully they can get another 10 million so they can last another quarter and get paid to doing nothing like they have for the last 25 years.

Cut them some slack they’re trying their hardest. They’ve frugally blown through $600,000,000.00 with zero to show for it. That’s not an easy task. Well done Pluristem. Any century now you’re gonna get it right.

👍️0

FDApproved 2月前

April 18th Company Presentation Out !!!

https://pluri-biotech.com/presentation/

👍️ 1

Scott999 2月前

Did you hear the news? Chairman Alejandro Weinstein’s throwing more bad money after more bad money. Yaki is so proud of this fool. Look at the statement below taken from the NR. Why hasn’t anyone other than this chump done this since they’re all so confident. Surely they could have bought some with the tens of millions in pay and free shares they’ve gifted themselves for doing literally nothing over the last 25 years. But on the bright side, they have a couple more weeks to keep it alive. Jokes and these legal scammers should all be in jail.

Yaky Yanay, Chief Executive Officer and President of Pluri, commented: "I believe Alejandro’s investment is a strong vote of confidence in the value of Pluri’s assets, platform, and future opportunities. We share the goal of unlocking this value through focused execution, strategic prioritization, and advancement of the initiatives we believe can create meaningful shareholder value."

👍️0

FDApproved 3月前

On February 27, 2026, the Company received a letter from Nasdaq, determining that the Company has regained compliance with Listing Rule 5550(b)(2)
See SEC Filing

👍️ 1

FDApproved 3月前

The partnership is already underway, with functional validation results expected in the coming months.
The partnership will evaluate how cell-based cacao can integrate across multiple categories including:
Beverages
Dairy
Confectionery
Industrial-scale testing will focus on functionality, sensory performance, and scalability — critical steps toward commercial validation.

https://futurefoodtechsf.com/articles/cargill-partners-kokomodo-advance-cell-based-cocoa-innovation-backed-eit-food

👍️ 1

FDApproved 3月前

Cargill-Kokomodo Collaboration Poised to Scale Cell-Based Cacao

https://www.foodingredientsfirst.com/news/cargill-kokomodo-scale-cell-based-cacao.html

👍️ 1

FDApproved 4月前

Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent

https://pluri-biotech.com/releases/pluri-secures-global-ip-position-with-china-patent-grant-for-large-scale-immune-cell-expansion-complementing-prior-u-s-patent/

👍️ 1

FDApproved 4月前

Israeli firm advances 3D cell tech to tackle disease, aging.

👍️ 1

Scott999 4月前

They’ve been going at this for 25 years now. Anyone see their latest revenue totals for the last 3 months. $198,000. Laughable just like the clowns running this, and Weinstein who’s desperately trying to save this pig and should just realized he got scammed like the rest of investors, and run for the hills. With their dwindling cash, he may not have a choice.

👍️0

FDApproved 4月前

Kokomodo and Cargill to test cell-based cocoa in industrial settings.

https://www.greenqueen.com.hk/cargill-kokomodo-cell-based-cocoa-lab-grown-chocolate-eit-food/

👍️ 1

FDApproved 4月前

Kokomodo and Cargill Partner Through EIT Food to Advance the Future of Sustainable Cacao Ingredients.

https://www.eitfood.eu/news/kokomodo-and-cargill-partner-through-eit-food

👍️ 1

FDApproved 4月前

Cargill is collaborating with Kokomodo, a leading agrifood-tech startup exploring cell-based cacao ingredients in controlled environments, through a proof-of-concept partnership supported by the European Institute of Innovation and Technology. Together, the teams are evaluating how these ingredients perform in real-world applications, focusing on advantaged functionality, sensory experience and scalability. The goal is to accelerate learning to pave the way for future commercialization.

https://www.cargill.com/story/chocolate-market-volatility-cargill-helping-customers-adapt

👍️ 1

FDApproved 4月前

Pluri showcases cell expansion platform as Resbiomed program advances

Pluri's Alejandro Weinstein on the future of cell-based technology

https://www.msn.com/en-us/technology/biotechnology/pluri-s-alejandro-weinstein-on-the-future-of-cell-based-technology/vi-AA1Vw2q8?ocid=BingNewsSerp

👍️ 1

FDApproved 4月前

The New Business Model: From Licensing to Value Creation

A critical component of this strategy is shifting from a passive licensing model to an active value-creation model. Rather than out-licensing technology for future royalties, Pluri is now focused on building independent companies.

The plan involves developing robust go-to-market strategies for each vertical and eventually spinning them off, taking them public, or engaging in M&A. Weinstein is moving the company into active M&A to generate immediate value for shareholders.

https://www.citybiz.co/article/799013/the-new-picasso-strategy-pluri-inc-unlocks-hidden-asset-value-through-vertical-focus/

👍️ 1

FDApproved 4月前

Landmark FDA Move: First Quality Control Protocol for Mesenchymal Stromal Cells (MSCs) Sets New Therapeutic Standard

https://www.prnewswire.com/news-releases/landmark-fda-move-first-quality-control-protocol-for-mesenchymal-stromal-cells-mscs-sets-new-therapeutic-standard-302668816.html

👍️ 1

FDApproved 4月前

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

https://markets.businessinsider.com/news/stocks/pluri-successfully-completes-first-phase-of-resbiomed-program-for-placenta-derived-collagen-rich-biomaterials-1035736678

👍️ 1

FDApproved 4月前

How Pluri Is Mass-Producing Cells to Solve Global Health & Food Challenges

👍️ 1

FDApproved 5月前

https://cellav.co/#about

👍️ 1

FDApproved 5月前

As cocoa chaos continues, Kokomodo finds its moment

https://www.foodnavigator.com/Article/2026/01/07/kokomodo-rises-as-cocoa-crisis-fuels-demand-for-cellgrown-cacao/

👍️ 1

FDApproved 5月前

The U.S. Food and Drug Administration (FDA) has authorized Mayo Clinic to offer Mesenchymal Stem Cells as part of the Regenerative Nephrology Compassionate Use Program.

https://www.mayo.edu/research/departments-divisions/department-internal-medicine/division-nephrology-hypertension/patient-care/regenerative-nephrology-compassionate-use-program

👍️ 1

FDApproved 5月前

January Company Presentation is Out! Lots of Significant Information !!! Pay Close Attention To Pages 13,20,21 !!!

https://pluri-biotech.com/presentation/

👍️ 1

FDApproved 5月前

Kokomodo/Coffeesai-The Cultured Hub unveils plant cell culturing for cocoa, coffee, and other ingredients

https://www.comunicaffe.com/the-cultured-hub-unveils-plant-cell-culturing-for-cocoa-coffee-and-other-ingredients/

👍️ 1

tw0122 6月前

$3.34 has my pump and dump approval

👍 1

FDApproved 6月前

Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries

https://pubmed.ncbi.nlm.nih.gov/41083142/

👍️ 1

FDApproved 7月前

Kokomodo Partners With Halba/Coop Switzerland to Explore Integration of Cultivated Cacao Into Confectionery Products

Halba is a Swiss chocolate manufacturer and a division of the Coop Group, which is a large Swiss retail, wholesale, and production company. Halba is one of the leading producers of sustainable Swiss chocolate, snacks, and baking ingredients, while the Coop Group has around 2,500 retail outlets in Switzerland and employs about 90,000 people.

https://cultivated-x.com/company-news/kokomodo-partners-coop-switzerland-explore-integration-cultivated-cacao-confectionery/

👍️ 1

Scott999 7月前

Will we get a Friday night raise? Have about 6 months before they run out of cash. Employees are fine as they’ve been collectively paid about half a billion dollars. Those great employees from vision systems Inc sure won the lottery getting involved with these charlatans.

👍️0

Scott999 7月前

More fluff than there are fluffers on a seniors porn set

👍️0

FDApproved 7月前

Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year

https://pluri-biotech.com/releases/pluri-and-subsidiaries-earn-multiple-industry-honors-named-as-overall-bioagriculture-company-of-the-year/

👍️0

Scott999 7月前

Over 20 years of headfakes and watching them blow through over half a BILLION dollars with literally zero to show for it. These guys are nothing more than a legal scam. You’re probably associated with part of the raise they’re most likely going to do on this little pump from the endless collaborations they do. Not one single thing they have promised over the last 25 years has come to fruition bud. But ya this time is different. Jokes

👍️0

FDApproved 7月前

MISS UNIVERSE SKINCARE offers a customized experience, formulated to enhance beauty, and build confidence that empowers you to be the star of your own universe.

https://missuniverseskincare.com/pages/our-story

👍️ 1

NY TO FL 7月前

I hope you sold all your shares because this stock is about to explode

👍 2 🤫 1

FDApproved 7月前

Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare

https://pluri-biotech.com/releases/pluri-partners-with-miss-universe-skincare-introducing-exosome-enhanced-regenerative-skincare/

👍️ 1

FDApproved 7月前

Press Release: Leading Global Players Back and Fund Pluri’s Cell-Based Food and Agriculture Collaborations

https://pluri-biotech.com/releases/leading-global-players-back-and-fund-pluris-cell-based-food-and-agriculture-collaborations/

👍️ 1

FDApproved 7月前

Development of PLX-R18, a promising and novel countermeasure for radiation-associated injuries.

https://www.sciencedirect.com/science/article/pii/S1359644625002156?via%3Dihub

👍️ 1

FDApproved 8月前

Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell Based Coffee Manufacturing in Mexico.

https://pluri-biotech.com/releases/pluri-subsidiary-coffeesai-and-instituto-del-cafe-de-chiapas-announce-strategic-collaboration-to-advance-cell-based-coffee-manufacturing-in-mexico/

👍️ 1

Scott999 8月前

Over 25 years of collaborations yet not a single one has turned into anything. They just Rob from their investors to the tune of over half a billion dollars. The epitome of charlatans

👍️0

Scott999 8月前

Crazy how it’s been 25 years now of these clowns literally stealing peoples money. Crazy this is allowed. Capitalism I guess.

👍️0

FDApproved 9月前

Great Interview With Pluri CEO !

https://open.spotify.com/episode/1Se6FCHVkGWsX2geg7cQCZ

👍️ 1

FDApproved 9月前

Pluri is Back in SEC Compliance After Appointment of A Director Yesterday!

https://www.sec.gov/ix?doc=/Archives/edgar/data/1158780/000121390025087052/ea0257121-8k_pluri.htm

👍️ 1

FDApproved 10月前

August 10th Company Presentation !!!

https://pluri-biotech.com/presentation/

👍️ 1

FDApproved 10月前

To illustrate the potential, Yanai explains that one large-scale PluriMatrix Cell Expansion System would be equivalent to growing and processing about 500,000 coffee bushes in traditional agriculture.

According to him, the Israeli Ministry of Health has already expressed its willingness to be among the world's leading regulators for the approval of cultured products, which can give Israel an advantage in the field of nutritional innovation.

"Our goal is not to replace traditional agriculture, but to complement it," Yanai emphasizes. "We tell the farmers: grow as much coffee as you can on the ground, and we will help you supplement the yield with our product."

https://www.israelhayom.co.il/tech/tech-news/article/18534641

👍️ 1

FDApproved 10月前

MAIT CELL PATENT !!!

38. The cell composition for use of claim 37, wherein the subject is afflicted with a tumor selected from the group consisting of: blood cancer, melanoma, breast cancer, colon cancer, kidney cancer, liver cancer, lung cancer, ovary cancer, pancreatic cancer, prostate cancer, uterine cancer, cervical cancer, bladder cancer, stomach cancer, head and neck cancer, brain cancer, skin cancer and sarcoma.

https://worldwide.espacenet.com/patent/search/family/094214915/publication/EP4572789A1?q=pn%3DEP4572789

👍️ 1

FDApproved 11月前

Is lab-grown coffee the future of the industry?

https://www.gcrmag.com/is-lab-grown-coffee-the-future-of-the-industry/

👍️ 1

Scott999 11月前

“Bühler aims to foster the development of equipment”

Wow you’d think they would say production or manufacturing then if they were just building them. Development means it’s. It ready. The 150 goons at Pluristem just pretend to work. That’s how in 25 years and over half a billion dollars spent they’re in the exact same boat they were in the beginning. No product, and pretty much zero revenue. Twenty five years is what startups always take.

👍️0

FDApproved 11月前

Buhler is Building Their Bioreactors !!! Pluri Is Not In The Business of Mass Production Of Bioreactors !!!
Wow !!! Your Ignorance Is Mind-Blowing !!!

👍️ 1

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Pluri Inc (PLUR)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Pluri Inc (PLUR) ニュース

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement

Form 8-K - Current report

Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

PLUR Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Pluri Inc (PLUR)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

Pluri Inc (PLUR) ニュース

Pluri Advances Toward U.S. Commercial Launch Through Its Subsidiary Cellav, Following Completion of Regenerative Aesthetic Products Listing

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 4 - Statement of changes in beneficial ownership of securities

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Pluri Secures Additional Investment from Chairman Alejandro Weinstein at 30% Premium to Market in a Private Placement

Form 8-K - Current report

Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Pluri Successfully Completes First Phase of Resbiomed Program for Placenta-Derived Collagen-Rich Biomaterials

PLUR Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する